Tumor cells in for instance lung and pancreatic cancer have been found to be capable of acquiring the ability to (over)express PD-L1 which facilitates immune evasion by reduction of the tumor-specific T cell function and is correlated with poor OS in several types of solid tumors (179, 180). This evidence concerns the gene CD274 and familial pancreatic carcinoma.